1. Report Introduction
2. Primary Progressive Multiple Sclerosis (PPMS) Epidemiology Overview at a Glance
3. Market Share Distribution of Primary Progressive Multiple Sclerosis (PPMS)
4. Disease Background and Overview: Primary Progressive Multiple Sclerosis (PPMS)
4.1. Introduction
4.2. Signs and Symptoms
4.3. Etiology
4.4. Risk Factors
4.5. Pathophysiology
4.6. Diagnostic Landscape
4.6.1. Diagnostic Practices
4.6.2. Diagnostic Criteria
4.6.3. Diagnostic Recommendations
4.7. Treatment Landscape
4.7.1. Current Treatment Practices
4.7.2. Treatment Algorithm
4.7.3. Treatment Recommendations
5. Primary Progressive Multiple Sclerosis (PPMS) Epidemiology
5.1. Key Findings
5.2. Assumptions & Rationale
5.3. 7MM Epidemiology
6. Epidemiology of Primary Progressive Multiple Sclerosis (PPMS) by Countries
7. United States
7.1. Assumptions and Rationale
7.2. Prevalent/Incident Cases of Primary Progressive Multiple Sclerosis (PPMS)
7.3. Sub-Type Specific cases of Primary Progressive Multiple Sclerosis (PPMS)*
7.4. Sex- Specific Cases of Primary Progressive Multiple Sclerosis (PPMS)*
7.5. Diagnosed Cases of Primary Progressive Multiple Sclerosis (PPMS)
7.6. Treated Cases of Primary Progressive Multiple Sclerosis (PPMS)
8. EU5
8.1. Germany
8.1.1. Assumptions and Rationale
8.1.2. Prevalent/Incident Cases of Primary Progressive Multiple Sclerosis (PPMS)
8.1.3. Sub-Type Specific cases of Primary Progressive Multiple Sclerosis (PPMS)*
8.1.4. Sex- Specific Cases of Primary Progressive Multiple Sclerosis (PPMS)*
8.1.5. Diagnosed Cases of Primary Progressive Multiple Sclerosis (PPMS)
8.1.6. Treated Cases of Primary Progressive Multiple Sclerosis (PPMS)
8.2. France
8.2.1. Assumptions and Rationale
8.2.2. Prevalent/Incident Cases of Primary Progressive Multiple Sclerosis (PPMS)
8.2.3. Sub-Type Specific cases of Primary Progressive Multiple Sclerosis (PPMS)*
8.2.4. Sex- Specific Cases of Primary Progressive Multiple Sclerosis (PPMS)*
8.2.5. Diagnosed Cases of Primary Progressive Multiple Sclerosis (PPMS)
8.2.6. Treated Cases of Primary Progressive Multiple Sclerosis (PPMS)
8.3. United Kingdom
8.3.1. Assumptions and Rationale
8.3.2. Prevalent/Incident Cases of Primary Progressive Multiple Sclerosis (PPMS)
8.3.3. Sub-Type Specific cases of Primary Progressive Multiple Sclerosis (PPMS)*
8.3.4. Sex- Specific Cases of Primary Progressive Multiple Sclerosis (PPMS)*
8.3.5. Diagnosed Cases of Primary Progressive Multiple Sclerosis (PPMS)
8.3.6. Treated Cases of Primary Progressive Multiple Sclerosis (PPMS)
8.4. Spain
8.4.1. Assumptions and Rationale
8.4.2. Prevalent/Incident Cases of Primary Progressive Multiple Sclerosis (PPMS)
8.4.3. Sub-Type Specific cases of Primary Progressive Multiple Sclerosis (PPMS)*
8.4.4. Sex- Specific Cases of Primary Progressive Multiple Sclerosis (PPMS)*
8.4.5. Diagnosed Cases of Primary Progressive Multiple Sclerosis (PPMS)
8.4.6. Treated Cases of Primary Progressive Multiple Sclerosis (PPMS)
8.5. Italy
8.5.1. Assumptions and Rationale
8.5.2. Prevalent/Incident Cases of Primary Progressive Multiple Sclerosis (PPMS)
8.5.3. Sub-Type Specific cases of Primary Progressive Multiple Sclerosis (PPMS)*
8.5.4. Sex- Specific Cases of Primary Progressive Multiple Sclerosis (PPMS)*
8.5.5. Diagnosed Cases of Primary Progressive Multiple Sclerosis (PPMS)
8.5.6. Treated Cases of Primary Progressive Multiple Sclerosis (PPMS)
9. Japan
9.1. Assumptions and Rationale
9.2. Prevalent/Incident Cases of Primary Progressive Multiple Sclerosis (PPMS)
9.3. Sub-Type Specific cases of Primary Progressive Multiple Sclerosis (PPMS)*
9.4. Sex- Specific Cases of Primary Progressive Multiple Sclerosis (PPMS)*
9.5. Diagnosed Cases of Primary Progressive Multiple Sclerosis (PPMS)
9.6. Treated Cases of Primary Progressive Multiple Sclerosis (PPMS)
10. Unmet Needs
Appendix
Report Methodology
Sources Used
Disclaimer
About CmaxInsight
*Indication Specific

Note: Certain sections of the table of contents would vary according to the availability of information.